We extracted from TCGA database from lung adenocarcinoma patients (among which 165 were nonsmokers and 361 were smokers) and lung squamous carcinoma patients (among which 86 were nonsmokers and 464 were smokers), 526 lung adenocarcinoma patients and 550 lung squamous carcinoma patients with EGFR expression, 585 lung adenocarcinoma patients and 550 lung squamous carcinoma patients with KRAS expression, and 527 lung adenocarcinoma patients and 502 lung squamous carcinoma patients with BRAF expression. This evidence concerns the gene KRAS and lung adenocarcinoma.